celastrol has been researched along with oxidopamine in 1 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | celastrol (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, N; Guo, L; Qu, B; Song, C; Sun, J; Zhu, S | 1 |
1 other study(ies) available for celastrol and oxidopamine
| Article | Year |
|---|---|
Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a/PI3K/Akt/mTOR signaling pathways in differentiated rat pheochromocytoma cells.
Topics: Adrenal Gland Neoplasms; Animals; Apoptosis; MicroRNAs; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Pentacyclic Triterpenes; Pheochromocytoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases | 2022 |